Table 4

Impact of PTS on QOL, general health and functioning

Cases with PTSCases without PTS
VariablesCategoriesNn (%)Nn (%)p Value*Adjusted p value†
QLIMean (SD)84 22.2 (3.6)118 24.0 (3.1)<0.001<0.001
GHQ-20Mean (SD)84 20.1 (6.1)118 17.6 (6.5)0.0060.003
Own health assessmentBad/very bad84 13 (15.5)117 7 (6.0)0.0270.029
How often experienced pain other than in the lower limbs?≥every week78 57 (73.1)114 31 (27.2)<0.001<0.001
Muscle skeletal problems‡Yes75 15 (20.0)113 11 (9.7)0.0460.076
Allergy‡Yes80 29 (36.3)114 31 (27.2)0.180.16
Constipation‡Yes75 13 (17.3)112 10 (8.9)0.0860.054
Skin problems‡Yes74 14 (18.9)114 9 (7.9)0.0240.033
Headache/Migraine‡Yes78 38 (48.7)114 46 (40.4)0.250.21
Psychiatric problems‡Yes74 18 (24.3)113 8 (7.1)0.001<0.001
Use of analgesic drugs ‡≥Every week83 16 (19.3)115 10 (8.7)0.0300.029
Use of allergy medicine‡≥Every week83 18 (21.7)112 10 (8.9)0.0120.017
Use of Dietary supplement ‡≥Every week84 37 (44.0)116 63 (54.3)0.820.76
Use of anticoagulants‡Every day81 16 (19.8)115 12 (10.4)0.0660.046
Physically worn out after a day's workOften/always81 44 (54.3)111 31 (27.9)<0.001<0.001
Mentally worn out after a day's workOften/ always85 54 (63.5)115 60 (52.2)0.110.16
Sick leave‡≥2 weeks79 35 (44.3)113 24 (21.2)0.001<0.001
  • *t Test for continuous variables and the Wald test for categorical variables.

  • †Adjusted for possible confounders (age) with linear regression for continuous variables and logistic regression for categorical variables.

  • ‡The last 12 months.

  • PTS, post-thrombosis syndrome; QOL, quality-of-life.